Pharmaceutical Executive Digest Europe - March 4, 2009 - (Page 3) Pharma MBAs: No Time Out Like the Present? Is now a good time, as pharma re-orients itself and the economy lies wounded, to invest in that MBA you’ve often thought of doing? Peter Houston looks at the pros and cons. O 2 FROM THE EDITOR / NEWS 3 11 PHARMA MBAs NEWS 6 BIO-ENTREPRENEUR SCHOOL 8 SALES FORCE EFFECTIVENESS 10 GSK’S PRICE CUTS 13 CALENDAR 14 ON THE MOVE JGI/Getty Images nce upon a time, back in those hazycrazy days of ’07 and ‘08, perfectly sane executives were known to talk quite seriously about quitting their well-paid jobs to do an MBA. Fast forward twelve months and only the certifiably insane would contemplate giving up a job, any job, for anything short of another job more secure than the one they already have. Every television or radio news broadcast is littered with stories of redundancies and layoffs. Throughout January and February this year, major job cuts at Pfizer–Wyeth, GSK and AstraZeneca have dominated the pharma headlines. The deepest cuts are in Big Pharma, but the small-to-medium enterprise (SME) sector is not immune — Fiercemarkets’ rundown of pharma layoffs makes for depressing reading. So, in a world where going backwards has become the new standing still, and standing still is the new going forwards, should you now be abandoning your dreams of MBA advancement, or at least putting them on hold? Going backwards has become the new standing still, and standing still is the new going forwards It would be understandable, but if you think about it, the potential costs of interrupting your career for a year or so are significantly lower when the economy is flat-lining. Take time out to study during a recession and you are less likely to be missing out on rapid promotions or juicy bonuses. http://www.fiercebiotech.com/tags/layoffs
Table of Contents Feed for the Digital Edition of Pharmaceutical Executive Digest Europe - March 4, 2009 Pharmaceutical Executive Digest Europe - March 4, 2009 Contents From the Editor Training and Development Sales Opinion Calendar On the Move Pharmaceutical Executive Digest Europe - March 4, 2009 Pharmaceutical Executive Digest Europe - March 4, 2009 - Contents (Page 1) Pharmaceutical Executive Digest Europe - March 4, 2009 - From the Editor (Page 2) Pharmaceutical Executive Digest Europe - March 4, 2009 - Training and Development (Page 3) Pharmaceutical Executive Digest Europe - March 4, 2009 - Training and Development (Page 4) Pharmaceutical Executive Digest Europe - March 4, 2009 - Training and Development (Page 5) Pharmaceutical Executive Digest Europe - March 4, 2009 - Training and Development (Page 6) Pharmaceutical Executive Digest Europe - March 4, 2009 - Training and Development (Page 7) Pharmaceutical Executive Digest Europe - March 4, 2009 - Sales (Page 8) Pharmaceutical Executive Digest Europe - March 4, 2009 - Sales (Page 9) Pharmaceutical Executive Digest Europe - March 4, 2009 - Opinion (Page 10) Pharmaceutical Executive Digest Europe - March 4, 2009 - Opinion (Page 11) Pharmaceutical Executive Digest Europe - March 4, 2009 - Opinion (Page 12) Pharmaceutical Executive Digest Europe - March 4, 2009 - Calendar (Page 13) Pharmaceutical Executive Digest Europe - March 4, 2009 - On the Move (Page 14)
For optimal viewing of this digital publication, please enable JavaScript and then refresh the page. If you would like to try to load the digital publication without using Flash Player detection, please click here.